Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
Sos ML; Michel K; Zander T; Weiss J; Frommolt P; Peifer M; Li D; Ullrich R; Koker M; Fischer F; Shimamura T; Rauh D; Mermel C; Fischer S; Stückrath I; Heynck S; Beroukhim R; Lin W; Winckler W; Shah K; LaFramboise T; Moriarty WF; Hanna M; Tolosi L; Rahnenführer J; Verhaak R; Chiang D; Getz G; Hellmich M; Wolf J; Girard L; Peyton M; Weir BA; Chen TH; Greulich H; Barretina J; Shapiro GI; Garraway LA; Gazdar AF; Minna JD; Meyerson M; Wong KK; Thomas RK; The Journal Of Clinical Investigation, 2009, vol. 119, issue 6, p 1727, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef